High-throughput screening with the Eimeria tenella CDC2-related kinase2/cyclin complex EtCRK2/EtCYC3a

Fernandez, M. L. S., Engels, K. K., Bender, F., Gassel, M., Marhofer, R. J., Mottram, J. C. and Selzer, P. M. (2012) High-throughput screening with the Eimeria tenella CDC2-related kinase2/cyclin complex EtCRK2/EtCYC3a. Microbiology, 158(9), pp. 2262-2271. (doi: 10.1099/mic.0.059428-0)

[img]
Preview
Text
73277.pdf - Published Version
Available under License Creative Commons Attribution.

1MB

Publisher's URL: http://dx.doi.org/10.1099/mic.0.059428-0

Abstract

The poultry disease coccidiosis, caused by infection with Eimeria spp. apicomplexan parasites, is responsible for enormous economic losses to the global poultry industry. The rapid increase of resistance to therapeutic agents, as well as the expense of vaccination with live attenuated vaccines, requires the development of new effective treatments for coccidiosis. Because of their key regulatory function in the eukaryotic cell cycle, cyclin-dependent kinases (CDKs) are prominent drug targets. The Eimeria tenella CDC2-related kinase 2 (EtCRK2) is a validated drug target that can be activated in vitro by the CDK activator XlRINGO (Xenopus laevis rapid inducer of G2/M progression in oocytes). Bioinformatics analyses revealed four putative E. tenella cyclins (EtCYCs) that are closely related to cyclins found in the human apicomplexan parasite Plasmodium falciparum. EtCYC3a was cloned, expressed in Escherichia coli and purified in a complex with EtCRK2. Using the non-radioactive time-resolved fluorescence energy transfer (TR-FRET) assay, we demonstrated the ability of EtCYC3a to activate EtCRK2 as shown previously for XlRINGO. The EtCRK2/EtCYC3a complex was used for a combined in vitro and in silico high-throughput screening approach, which resulted in three lead structures, a naphthoquinone, an 8-hydroxyquinoline and a 2-pyrimidinyl-aminopiperidine-propane-2-ol. This constitutes a promising starting point for the subsequent lead optimization phase and the development of novel anticoccidial drugs.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Selzer, Dr Paul and Mottram, Professor Jeremy
Authors: Fernandez, M. L. S., Engels, K. K., Bender, F., Gassel, M., Marhofer, R. J., Mottram, J. C., and Selzer, P. M.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Microbiology
Publisher:Society for General Microbiology
ISSN:1350-0872
ISSN (Online):1465-2080
Published Online:21 June 2012
Copyright Holders:Copyright © 2012 The Authors
First Published:First published in Microbiology 158(9):2262-2271
Publisher Policy:Reproduced under a Creative Commons License
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
454141Analysing the roles of petidases in Leishmania infectivity and pathogenicityJeremy MottramMedical Research Council (MRC)G0700127III - PARASITOLOGY